Daisy Obispo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Daisy Obispo has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Oscar Acosta
Centro de Genética y Biología Molecular, Facultad de Medicina Humana, Universidad de San Martin de Porres, Lima 15024, Peru
5 shared publications - Ricardo Fujita
Universidad de San Martín de Porres, Peru
5 shared publications - María Luisa Guevara-Fujita
Centro de Genética y Biología Molecular, Facultad de Medicina Humana, Universidad de San Martín de Porres, Alameda del Corregidor 1531, Lima 15024, Peru
4 shared publications - María Dedios Alegría
Hospital Santa Rosa, Lima 15001, Peru
2 shared publications - Susan Echavarria
Laboratorio de Referencia Nacional de Virus de Transmisión Sexual–Instituto Nacional de Salud, Facultad de Medicina Humana, Universidad de San Martín de Porres, Lima 15001, Peru
2 shared publications - Susan Espetia
Laboratorio de Referencia Nacional de Virus de Transmisión Sexual–Instituto Nacional de Salud, Facultad de Medicina Humana, Universidad de San Martín de Porres, Lima 15001, Peru
2 shared publications
Latest Publications
- Open Access
Comparative Transcriptomic Analysis of Alpaca (Vicugna pacos) Skin Identifies Candidate Genes and Biological Processes Associated with Fiber Color
The transcriptomic basis of natural fiber-color diversity in alpacas remains incompletely understood. We analyzed skin biopsies from 65 Huacaya alpacas by RNA sequencing (RNA-seq) and integrated phenotypic color categories with instrumental Commission Internationale de l′Éclairage L*a*b* CIELAB measurements, a standardized color space system used to objectively measure and quantify color. Differential expression was assessed using DESeq2 differential-expression analysis package with adjustment for collection batch, sex, and fiber-color category, while L* (lightness), a* (green–red axis), and b* (blue–yellow axis) were examined in separate continuous models. The categorical analysis included 64 samples and 25,405 genes. We identified 4968, 3993, 1469, and 7607 differentially expressed genes in light brown (LB), dark brown (DB), light fawn intensity Y (LFY), and light fawn intensity Z (LFZ), respectively, relative to white (W), with higher expression predominating in pigmented categories. Global transcriptomic structure and gene-level expression patterns were associated with CIELAB parameters, supporting the use of these measurements as complementary quantitative descriptors of fiber color. However, these associations should be interpreted cautiously because of the imbalance between collection batches and the heterogeneous cellular composition of the skin biopsies. Integration of categorical, continuous, and functional evidence prioritized TYR (tyrosinase), TYRP1 (tyrosinase-related protein 1), MITF (melanocyte-inducing transcription factor), EDNRB (endothelin receptor type B), MFSD12 (major facilitator superfamily domain containing 12), and GPR143 (G protein-coupled receptor 143), among other genes. Two regions with unassigned locus (LOC) identifiers in VicPac4 showed evidence consistent with premelanosome protein (PMEL), and a third with OCA2 melanosomal transmembrane protein (OCA2/P), although these identities remained interpretive proposal. Genes with higher expression in pigmented categories were overrepresented in pigmentation and melanosome processes, whereas genes with lower expression were associated with epidermal and keratin-related processes. These findings identify transcriptomic changes associated with natural fiber-color variation and candidates for functional validation.
Open AccessComparative Transcriptomic Analysis of Alpaca (Vicugna pacos) Skin Identifies Candidate Genes and Biological Processes Associated with Fiber Color
The transcriptomic basis of natural fiber-color diversity in alpacas remains incompletely understood. We analyzed skin biopsies from 65 Huacaya alpacas by RNA sequencing (RNA-seq) and integrated phenotypic color categories with instrumental Commission Internationale de l′Éclairage L*a*b* CIELAB measurements, a standardized color space system used to objectively measure and quantify color. Differential expression was assessed using DESeq2 differential-expression analysis package with adjustment for collection batch, sex, and fiber-color category, while L* (lightness), a* (green–red axis), and b* (blue–yellow axis) were examined in separate continuous models. The categorical analysis included 64 samples and 25,405 genes. We identified 4968, 3993, 1469, and 7607 differentially expressed genes in light brown (LB), dark brown (DB), light fawn intensity Y (LFY), and light fawn intensity Z (LFZ), respectively, relative to white (W), with higher expression predominating in pigmented categories. Global transcriptomic structure and gene-level expression patterns were associated with CIELAB parameters, supporting the use of these measurements as complementary quantitative descriptors of fiber color. However, these associations should be interpreted cautiously because of the imbalance between collection batches and the heterogeneous cellular composition of the skin biopsies. Integration of categorical, continuous, and functional evidence prioritized TYR (tyrosinase), TYRP1 (tyrosinase-related protein 1), MITF (melanocyte-inducing transcription factor), EDNRB (endothelin receptor type B), MFSD12 (major facilitator superfamily domain containing 12), and GPR143 (G protein-coupled receptor 143), among other genes. Two regions with unassigned locus (LOC) identifiers in VicPac4 showed evidence consistent with premelanosome protein (PMEL), and a third with OCA2 melanosomal transmembrane protein (OCA2/P), although these identities remained interpretive proposal. Genes with higher expression in pigmented categories were overrepresented in pigmentation and melanosome processes, whereas genes with lower expression were associated with epidermal and keratin-related processes. These findings identify transcriptomic changes associated with natural fiber-color variation and candidates for functional validation.
- Open Access
- 22 October 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (11) , 1096
Plasma hsa-miRNA-145 Levels in Peruvian Women: In Silico Analysis and Inferences for Breast Cancer
MicroRNAs (miRNAs) are small non-coding sequences that regulate gene expression at the post-transcriptional level in various biological processes (including differentiation, cell proliferation, cell cycle and apoptosis). Low levels of human miRNA-145 (hsa-miRNA-145) expression have been found in the plasma of cancer patients, suggesting that it is a tumor suppressor. Newly developed molecular biology technologies such as digital PCR (dPCR) have high sensitivity and specificity for evaluating miRNAs, with potential value for hsa-miRNA-145 analyses. This study involved the evaluation of circulating hsa-miRNA-145 levels in the plasma of Peruvian women using digital dPCR, along with in silico analysis of its metabolic impact on cancer. This study included plasma samples from 30 women residing in Lima (aged 20–67). All individuals had previously received negative breast cancer screening results between 2016 and 2018. We used a chip-based amplification platform (dPCR system) to analyze their hsa-miRNA-145 levels and compare them with those reported in breast cancer patients. These patients had significantly lower levels. In the in silico analysis, 35 target transcripts belonging to signaling and metabolic pathways associated with the variation in hsa-miRNA-145 levels in breast and ovarian cancer were identified. Specifically, hsa-miRNA-145 was predicted to significantly impact calcium, cell proliferation, metastasis, and glucose/glutamine metabolism, with effects on the CAMK2D, EGFR, TP53, hexokinase 2 (HK2), and glutaminase (GLS) genes. This research deepens our understanding of the epigenetic factors involved in breast cancer, including plasma miRNA-145 levels, as well as associated metabolic pathways, which could promote precision medicine for Peruvian cancer patients.
- 22 October 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (11) , 1096
Open AccessPlasma hsa-miRNA-145 Levels in Peruvian Women: In Silico Analysis and Inferences for Breast Cancer
MicroRNAs (miRNAs) are small non-coding sequences that regulate gene expression at the post-transcriptional level in various biological processes (including differentiation, cell proliferation, cell cycle and apoptosis). Low levels of human miRNA-145 (hsa-miRNA-145) expression have been found in the plasma of cancer patients, suggesting that it is a tumor suppressor. Newly developed molecular biology technologies such as digital PCR (dPCR) have high sensitivity and specificity for evaluating miRNAs, with potential value for hsa-miRNA-145 analyses. This study involved the evaluation of circulating hsa-miRNA-145 levels in the plasma of Peruvian women using digital dPCR, along with in silico analysis of its metabolic impact on cancer. This study included plasma samples from 30 women residing in Lima (aged 20–67). All individuals had previously received negative breast cancer screening results between 2016 and 2018. We used a chip-based amplification platform (dPCR system) to analyze their hsa-miRNA-145 levels and compare them with those reported in breast cancer patients. These patients had significantly lower levels. In the in silico analysis, 35 target transcripts belonging to signaling and metabolic pathways associated with the variation in hsa-miRNA-145 levels in breast and ovarian cancer were identified. Specifically, hsa-miRNA-145 was predicted to significantly impact calcium, cell proliferation, metastasis, and glucose/glutamine metabolism, with effects on the CAMK2D, EGFR, TP53, hexokinase 2 (HK2), and glutaminase (GLS) genes. This research deepens our understanding of the epigenetic factors involved in breast cancer, including plasma miRNA-145 levels, as well as associated metabolic pathways, which could promote precision medicine for Peruvian cancer patients.
- Open Access
- 19 July 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (7) , 1573
Exploratory Genomic Characterisation of the Resistome, Virulome and Molecular Epidemiology of Multidrug-Resistant Klebsiella pneumoniae Clinical Isolates from Four Peruvian Regions
Multidrug-resistant (MDR) Klebsiella pneumoniae is a critical cause of nosocomial infections associated with high mortality. Of particular concern is the genomic convergence of multidrug resistance and hypervirulence (MDR-hvKP), which represents a severe public health threat. This study characterised the resistome, virulome, and population structure of seven clinical MDR K. pneumoniae isolates collected between 2024 and 2025 across four Peruvian regions (Moquegua, Ucayali, Loreto, and Lima) using whole-genome sequencing (WGS). Genomic analysis identified six distinct sequence types, with the high-risk clone ST307 being the most prevalent (2/7 isolates), consistently associated with the KL102 capsular locus. Remarkably, one isolate from Loreto (oph_54) exhibited a convergent MDR-hvKP genomic profile (ST218, KL57, virulence score 4), carrying yersiniabactin, salmochelin (iro), and aerobactin (iuc) loci alongside multiple resistance determinants. The isolates presented a robust resistome dominated by the extended-spectrum beta-lactamase gene blaCTX-M-15 (5/7) and blaOXA-1, coupled with aac(6′)-Ib-cr and fosA6 genes. Plasmid analysis revealed a predominance of IncFIB(K) replicons. Although exploratory, these findings demonstrate the regional presence of high-risk ST307 lineages and the emergence of convergent MDR-hvKP genomic profiles within the analysed Peruvian hospitals. Immediate and continuous genomic surveillance is urgently required to monitor the potential spread of these highly dangerous, MDR bacterial lineages within these healthcare environments.
- 19 July 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (7) , 1573
Open AccessExploratory Genomic Characterisation of the Resistome, Virulome and Molecular Epidemiology of Multidrug-Resistant Klebsiella pneumoniae Clinical Isolates from Four Peruvian Regions
Multidrug-resistant (MDR) Klebsiella pneumoniae is a critical cause of nosocomial infections associated with high mortality. Of particular concern is the genomic convergence of multidrug resistance and hypervirulence (MDR-hvKP), which represents a severe public health threat. This study characterised the resistome, virulome, and population structure of seven clinical MDR K. pneumoniae isolates collected between 2024 and 2025 across four Peruvian regions (Moquegua, Ucayali, Loreto, and Lima) using whole-genome sequencing (WGS). Genomic analysis identified six distinct sequence types, with the high-risk clone ST307 being the most prevalent (2/7 isolates), consistently associated with the KL102 capsular locus. Remarkably, one isolate from Loreto (oph_54) exhibited a convergent MDR-hvKP genomic profile (ST218, KL57, virulence score 4), carrying yersiniabactin, salmochelin (iro), and aerobactin (iuc) loci alongside multiple resistance determinants. The isolates presented a robust resistome dominated by the extended-spectrum beta-lactamase gene blaCTX-M-15 (5/7) and blaOXA-1, coupled with aac(6′)-Ib-cr and fosA6 genes. Plasmid analysis revealed a predominance of IncFIB(K) replicons. Although exploratory, these findings demonstrate the regional presence of high-risk ST307 lineages and the emergence of convergent MDR-hvKP genomic profiles within the analysed Peruvian hospitals. Immediate and continuous genomic surveillance is urgently required to monitor the potential spread of these highly dangerous, MDR bacterial lineages within these healthcare environments.
- Open Access
New Associations with the HIV Predisposing and Protective Alleles of the Human Leukocyte Antigen System in a Peruvian Population
The accurate determination of an individual’s unique human leukocyte antigen (HLA) allele holds important significance in evaluating the risk associated with autoimmune and infectious diseases, such as human immunodeficiency virus (HIV) infection. Several allelic variants within the HLA system have been linked to either increased protection or susceptibility in the context of infectious and autoimmune diseases. This study aimed to determine the frequency and association of HLA alleles between people living with HIV (PLHIV) as the case group and Peruvian individuals without HIV with high-risk behaviors of sexually transmitted diseases as the control group. Whole exome sequencing (WES) was used to determine high-resolution HLA allelotypes using the OptiType and arcas HLA tools. The HLA alleles present in HLA classes I (A, B, and C loci) and II (DPB1, DQA1, DQB1, and DRB1 loci) were determined in a cohort of 59 PLHIV (cases) and 44 individuals without HIV (controls). The most frequent HLA alleles were A*02:01, DPB1*04:02, and DQB1*03:419 at 36%, 30%, and 28% prevalence in general population. We found that C*07:01 (p = 0.0101; OR = 10.222, 95% IC: 1.40–74.55), DQA1*03:02 (p = 0.0051; OR = 5.297, 95% IC: 1.48–19.02), and DRB1*09:01 (p = 0.0119; OR = 4.788, 95% IC: 1.39–16.44) showed an association with susceptibility to HIV infection, while DQB1*03:419 (p = 0.0478; OR = 0.327, 95% IC: 0.11–0.96) was associated with protection from HIV infection. Our findings contribute to the knowledge of HLA allele diversity in the Peruvian population (around 70% South American indigenous ancestry) lays the groundwork for further valuable large-scale use of HLA typing and offers a novel association with HIV infection that is relevant to vaccine studies.
Open AccessNew Associations with the HIV Predisposing and Protective Alleles of the Human Leukocyte Antigen System in a Peruvian Population
The accurate determination of an individual’s unique human leukocyte antigen (HLA) allele holds important significance in evaluating the risk associated with autoimmune and infectious diseases, such as human immunodeficiency virus (HIV) infection. Several allelic variants within the HLA system have been linked to either increased protection or susceptibility in the context of infectious and autoimmune diseases. This study aimed to determine the frequency and association of HLA alleles between people living with HIV (PLHIV) as the case group and Peruvian individuals without HIV with high-risk behaviors of sexually transmitted diseases as the control group. Whole exome sequencing (WES) was used to determine high-resolution HLA allelotypes using the OptiType and arcas HLA tools. The HLA alleles present in HLA classes I (A, B, and C loci) and II (DPB1, DQA1, DQB1, and DRB1 loci) were determined in a cohort of 59 PLHIV (cases) and 44 individuals without HIV (controls). The most frequent HLA alleles were A*02:01, DPB1*04:02, and DQB1*03:419 at 36%, 30%, and 28% prevalence in general population. We found that C*07:01 (p = 0.0101; OR = 10.222, 95% IC: 1.40–74.55), DQA1*03:02 (p = 0.0051; OR = 5.297, 95% IC: 1.48–19.02), and DRB1*09:01 (p = 0.0119; OR = 4.788, 95% IC: 1.39–16.44) showed an association with susceptibility to HIV infection, while DQB1*03:419 (p = 0.0478; OR = 0.327, 95% IC: 0.11–0.96) was associated with protection from HIV infection. Our findings contribute to the knowledge of HLA allele diversity in the Peruvian population (around 70% South American indigenous ancestry) lays the groundwork for further valuable large-scale use of HLA typing and offers a novel association with HIV infection that is relevant to vaccine studies.
- Open Access
- 16 October 2024
- Published by Elsevier in Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
- Vol. 37, 100485
Variants in the N-acetyltranferase 2 gene, acetylator phenotypes and their association with tuberculosis: Findings in Peruvian patients
- 16 October 2024
- Published by Elsevier in Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
- Vol. 37, 100485
Open AccessVariants in the N-acetyltranferase 2 gene, acetylator phenotypes and their association with tuberculosis: Findings in Peruvian patients
- Open Access
- 1 October 2024
- Published by MDPI AG in Preprints.org
New Associations with HIV Predisposing and Protective Alleles of the HLA System in a Peruvian Population
Accurate determination of an individual’s unique human leukocyte antigen (HLA) allele holds important significance in evaluating the risk associated with autoimmune and infectious diseases, such as human immunodeficiency virus (HIV) infection. Several allelic variants within the HLA system have been linked to either increased protection or susceptibility in the context of infectious and autoimmune diseases. This study aimed to determine the frequency and association of HLA alleles between people living with HIV (PLHIV) as the case group and HIV-uninfected Peruvian individuals with high-risk behavior of sexual transmission diseases as the control group. Whole exome sequencing (WES) was used to determine high-resolution HLA allelotypes using OptiType and arcasHLA tools. The HLA alleles present in HLA classes I (A, B, and C loci) and II (DPA1, DPB1, DQA1, DQB1 and DRB1 loci) were determined in a cohort of 59 PLHIV (cases) and 44 HIV-uninfected individuals (controls). The most frequent HLA alleles were A*02:01, DPB1*04:02 and DQB1*03:419 at 36%, 30% and 28% prevalence in general population. We found that C*07:01 (p = 0.0101; OR = 10.222, 95% IC: 1.40–74.55), DQA1*03:02 (p = 0.0051; OR = 5.297, 95% IC: 1.48–19.02) and DRB1*09:01 (p = 0.0119; OR = 4.788, 95% IC: 1.39–16.44) showed an association with susceptibility to HIV infection, while DQB1*03:419 (p = 0.0478; OR = 0.327, 95% IC: 0.11–0.96) was associated with protection from HIV infection. Our findings contribute to the knowledge of HLA allele diversity in the Peruvian population (around 70% South American indigenous ancestry), lay the groundwork for further valuable large-scale use of HLA typing and offer a novel association of HIV infection that is relevant to vaccine studies.
- 1 October 2024
- Published by MDPI AG in Preprints.org
Open AccessNew Associations with HIV Predisposing and Protective Alleles of the HLA System in a Peruvian Population
Accurate determination of an individual’s unique human leukocyte antigen (HLA) allele holds important significance in evaluating the risk associated with autoimmune and infectious diseases, such as human immunodeficiency virus (HIV) infection. Several allelic variants within the HLA system have been linked to either increased protection or susceptibility in the context of infectious and autoimmune diseases. This study aimed to determine the frequency and association of HLA alleles between people living with HIV (PLHIV) as the case group and HIV-uninfected Peruvian individuals with high-risk behavior of sexual transmission diseases as the control group. Whole exome sequencing (WES) was used to determine high-resolution HLA allelotypes using OptiType and arcasHLA tools. The HLA alleles present in HLA classes I (A, B, and C loci) and II (DPA1, DPB1, DQA1, DQB1 and DRB1 loci) were determined in a cohort of 59 PLHIV (cases) and 44 HIV-uninfected individuals (controls). The most frequent HLA alleles were A*02:01, DPB1*04:02 and DQB1*03:419 at 36%, 30% and 28% prevalence in general population. We found that C*07:01 (p = 0.0101; OR = 10.222, 95% IC: 1.40–74.55), DQA1*03:02 (p = 0.0051; OR = 5.297, 95% IC: 1.48–19.02) and DRB1*09:01 (p = 0.0119; OR = 4.788, 95% IC: 1.39–16.44) showed an association with susceptibility to HIV infection, while DQB1*03:419 (p = 0.0478; OR = 0.327, 95% IC: 0.11–0.96) was associated with protection from HIV infection. Our findings contribute to the knowledge of HLA allele diversity in the Peruvian population (around 70% South American indigenous ancestry), lay the groundwork for further valuable large-scale use of HLA typing and offer a novel association of HIV infection that is relevant to vaccine studies.